More details on implementation, evaluation metrics, docking methods, compound desgin and synthesis and additional results in teh dark chemical genomics sequence exploration. Table A: Model architecture configuration. Table B: 65 compounds tested for selective dual DRD1/3 antagonists. Table C: Undruggable human disease-associated proteins selected by ProtalCG. Table D: Predicted ligands for the transcription factors and transcription activity related proteins. Table E: Chemicals interacted with undruggable human proteins. Table F: Targets predicted by PortalCG for AI-10–49, fenebrutinib, PF-05190457 and their docking score from Autodock Vina. Table G: Functional Annotation enrichment for human proteins in Tbio selected by PortalCG. Table H: ...
(A) Design Scheme of PortalCG: PortalCG enables the prediction of chemical-protein interactions (CPI...
Objective: Mechanistic study of newly reported anti-Parkinson agents by molecular docking to predict...
<p>(A) Distribution of existing drug targets, PDB structures, and homology models in the human genom...
(A) The chemical scaffold on which 65 compounds were synthesized as potential selective dual-DRD1/DR...
In toxicogenomics, functional annotation is an important step to gain additional insights into genes...
Chemical-genetic interactions–observed when the treatment of mutant cells with chemical compounds re...
Each panel shows, for a bioprocess and either a compound (A) or a set of compounds (B-C) predicted t...
A promising protein target for computational drug development, the human cluster of differentiation ...
Chemists are inundated with vast amounts of raw data: spectral data, synthetic data, stereochemicall...
University of Minnesota Ph.D. dissertation. April 2019. Major: Biomedical Informatics and Computatio...
Perturbed bioprocesses were predicted using both CG-TARGET and a method that calculated enrichment o...
Recovery of the P53 tumour suppressor pathway via small molecule inhibitors of onco-protein MDM2 hig...
In order for molecular docking to become a driving force in drug discovery, it should demonstrate a ...
Due to evolutionary conservation of biology, experimental knowledge captured from genetic studies in...
In toxicogenomics, functional annotation is an important step to gain additional insights into genes...
(A) Design Scheme of PortalCG: PortalCG enables the prediction of chemical-protein interactions (CPI...
Objective: Mechanistic study of newly reported anti-Parkinson agents by molecular docking to predict...
<p>(A) Distribution of existing drug targets, PDB structures, and homology models in the human genom...
(A) The chemical scaffold on which 65 compounds were synthesized as potential selective dual-DRD1/DR...
In toxicogenomics, functional annotation is an important step to gain additional insights into genes...
Chemical-genetic interactions–observed when the treatment of mutant cells with chemical compounds re...
Each panel shows, for a bioprocess and either a compound (A) or a set of compounds (B-C) predicted t...
A promising protein target for computational drug development, the human cluster of differentiation ...
Chemists are inundated with vast amounts of raw data: spectral data, synthetic data, stereochemicall...
University of Minnesota Ph.D. dissertation. April 2019. Major: Biomedical Informatics and Computatio...
Perturbed bioprocesses were predicted using both CG-TARGET and a method that calculated enrichment o...
Recovery of the P53 tumour suppressor pathway via small molecule inhibitors of onco-protein MDM2 hig...
In order for molecular docking to become a driving force in drug discovery, it should demonstrate a ...
Due to evolutionary conservation of biology, experimental knowledge captured from genetic studies in...
In toxicogenomics, functional annotation is an important step to gain additional insights into genes...
(A) Design Scheme of PortalCG: PortalCG enables the prediction of chemical-protein interactions (CPI...
Objective: Mechanistic study of newly reported anti-Parkinson agents by molecular docking to predict...
<p>(A) Distribution of existing drug targets, PDB structures, and homology models in the human genom...